Diansong Zhou
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 24
- Antibiotics Pharmacokinetics and Efficacy 12
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 6
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 24
- Antibiotics Pharmacokinetics and Efficacy 12
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 11
- Cancer Immunotherapy and Biomarkers 6
-
- Lung Cancer Treatments and Mutations 7
-
- Computational Drug Discovery Methods 6
-
- Pharmaceutical studies and practices 5
- Co-authors
- Nidal Al‐HunitiScott GrimmKhanh BuiTommy B. AnderssonHongmei XuTrevor N. JohnsonRuifeng LiuJian Guo
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Diansong Zhou
85 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 120
- Pharmacology 382
- Molecular Medicine 163
- Applied Microbiology and Biotechnology 50
- Pharmacology 383
- Oncology 301
Countries citing papers authored by Diansong Zhou
This map shows the geographic impact of Diansong Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diansong Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diansong Zhou more than expected).
Fields of papers citing papers by Diansong Zhou
This network shows the impact of papers produced by Diansong Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diansong Zhou. The network helps show where Diansong Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Diansong Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 21 | |
| 12 | 2022 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 10 | |
| 15 | 2020 | 4 | |
| 16 | 2017 | 7 | |
| 17 | 2015 | 7 | |
| 18 | 2011 | 6 | |
| 19 | 2011 | 5 | |
| 20 | 1998 | 10 |
About Diansong Zhou
Diansong Zhou is a scholar working on Pharmacology, Oncology and Molecular Medicine, having authored 87 papers that have together received 1.4k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (24 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers), Drug Transport and Resistance Mechanisms (11 papers), Lung Cancer Treatments and Mutations (7 papers), Computational Drug Discovery Methods (6 papers), Antibiotic Resistance in Bacteria (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Pharmaceutical studies and practices (5 papers). The work is most often cited by research in Pharmacology (382 citations), Molecular Medicine (163 citations) and Applied Microbiology and Biotechnology (50 citations). Diansong Zhou has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Nidal Al‐Huniti, Scott Grimm, Khanh Bui, Tommy B. Andersson, Hongmei Xu, Trevor N. Johnson, Ruifeng Liu, Jian Guo, Wangda Zhou and Shampa Das.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.